These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31351132)

  • 1. Reply.
    Kennedy NA; Lees CW
    Clin Gastroenterol Hepatol; 2020 Feb; 18(2):526. PubMed ID: 31351132
    [No Abstract]   [Full Text] [Related]  

  • 2. Preanalytical Heterogeneity in Fecal Calprotectin Measurement Needs To Be Considered for Tight Control.
    Pansart C; Roblin X; Paul S
    Clin Gastroenterol Hepatol; 2020 Feb; 18(2):524-525. PubMed ID: 31937401
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to can fecal calprotection identify postoperative recurrence of Crohn's disease?
    Qiu Y
    Inflamm Bowel Dis; 2015 May; 21(5):E7. PubMed ID: 25856771
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Dr. Papamichael et al.'s letter.
    Lobatón T; Rodríguez-Moranta F; Guardiola J
    J Crohns Colitis; 2013 Dec; 7(12):e702-3. PubMed ID: 24029443
    [No Abstract]   [Full Text] [Related]  

  • 5. Authors' reply: The Association Between Visceral Adipose Tissue and Stricturing Crohn's Disease Behavior, Fecal Calprotectin and Quality of Life.
    Bryant RV; Schultz CG; Ooi S; Goess C; Costello SP; Vincent AD; Schoeman S; Lim A; Bartholomeusz FD; Travis SPL; Andrews JM
    Inflamm Bowel Dis; 2019 May; 25(6):e62-e63. PubMed ID: 30380064
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: reproducible evidence shows that exclusive enteral nutrition significantly reduces faecal calprotectin concentrations in children with active Crohn's disease-Authors' reply.
    Feathers A; Swaminath A; Ananthakrishnan AN; Falzon L; Li Ferry S
    Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1121. PubMed ID: 29105134
    [No Abstract]   [Full Text] [Related]  

  • 7. Fecal calprotectin in Crohn's disease: new family ties.
    Tamboli CP; Richard F; Colombel JF
    Gastroenterology; 2003 Jun; 124(7):1972-4. PubMed ID: 12806631
    [No Abstract]   [Full Text] [Related]  

  • 8. Fecal calprotectin variability in Crohn's disease.
    Moum B; Jahnsen J; Bernklev T
    Inflamm Bowel Dis; 2010 Jul; 16(7):1091-2. PubMed ID: 19834972
    [No Abstract]   [Full Text] [Related]  

  • 9. Level of Fecal Calprotectin and the Severity of Small Bowel Crohn's Disease.
    Dai C; Sun MJ; Jiang M
    Clin Gastroenterol Hepatol; 2017 Feb; 15(2):320-321. PubMed ID: 27670382
    [No Abstract]   [Full Text] [Related]  

  • 10. Can fecal calprotection identify postoperative recurrence of Crohn's disease?
    Dai C; Jiang M; Sun MJ
    Inflamm Bowel Dis; 2015 May; 21(5):E7. PubMed ID: 25895009
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply.
    Dreesen E; Gils A
    Clin Gastroenterol Hepatol; 2020 Jan; 18(1):262-263. PubMed ID: 31254674
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply.
    Dreesen E; Vermeire S
    Clin Gastroenterol Hepatol; 2020 Oct; 18(11):2632-2633. PubMed ID: 32200086
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial: the reduction of faecal calprotectin during exclusive enteral nutrition is lost rapidly after food reintroduction.
    Wall CL; Day AS
    Aliment Pharmacol Ther; 2019 Oct; 50(7):824-825. PubMed ID: 31532560
    [No Abstract]   [Full Text] [Related]  

  • 14. The Association Between Visceral Adipose Tissue and Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life.
    Dai C; Jiang M; Huang YH
    Inflamm Bowel Dis; 2019 May; 25(6):e61. PubMed ID: 30380063
    [No Abstract]   [Full Text] [Related]  

  • 15. Is fecal calprotectin useful for monitoring endoscopic disease activity in patients with postoperative Crohn's disease?
    Yamamoto T; Kotze PG
    J Crohns Colitis; 2013 Dec; 7(12):e712. PubMed ID: 23999186
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to Dai et al.
    Boschetti G; Drai J; Flourié B; Nancey S
    Am J Gastroenterol; 2015 Aug; 110(8):1242. PubMed ID: 26263365
    [No Abstract]   [Full Text] [Related]  

  • 17. Fecal Calprotectin as a Predictor of Relapse in Patients With Inflammatory Bowel Disease.
    Dai C; Jiang M; Sun MJ
    J Clin Gastroenterol; 2015 Sep; 49(8):715. PubMed ID: 25984977
    [No Abstract]   [Full Text] [Related]  

  • 18. Fecal Calprotectin in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease.
    Dai C; Jiang M; Sun MJ
    Dig Dis Sci; 2017 Dec; 62(12):3625-3626. PubMed ID: 29043593
    [No Abstract]   [Full Text] [Related]  

  • 19. Added Value of Fecal Calprotectin to Support the Diagnosis of Spondyloarthropathies.
    VAN Hoovels L; VAN DEN Bremt S; Schiemsky T; Cauchie M; Vander Cruyssen B; Bossuyt X; VAN DER Steen K; Stubbe M
    J Rheumatol; 2019 Feb; 46(2):215-216. PubMed ID: 30710003
    [No Abstract]   [Full Text] [Related]  

  • 20. Serial fecal calprotectin measurements to detect endoscopic recurrence in postoperative Crohn's disease: is colonoscopic surveillance no longer needed?
    Schoepfer AM; Lewis JD
    Gastroenterology; 2015 May; 148(5):889-92. PubMed ID: 25805423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.